Here's what we'll cover Key takeaways Wegovy (semaglutide) is an injectable medication for weight loss and preventing major cardiovascular events in people with heart disease and obesity or overweight
35,36 While the subsequent GUIDE-HF trial did not find a difference in cardiovascular outcomes using PA pressure monitoring, a newly published trial based out of Europe, MONITOR-HF, demonstrated findings similar to the earlier CHAMPION trial that PA pressure monitoring to guide HF management reduced HF-related hospitalizations and improved quality of life
Work with your healthcare team to finalise: Also, consult your pharmacist about proper medication storage, timing, and any potential interactions with other medications or supplements
Body weight and weight change and their health implications for the elderly
If ketoacidosis is suspected, discontinue FARXIGA, promptly evaluate, and treat ketoacidosis, if confirmed